We partner with business builders creating long-term transformational economic and societal value.
Portfolio Spotlight
Backed by Echo, Zeno’s new Energy Operating System optimizes the financial performance of energy assets.
Learn More
Portfolio Spotlight
Wheeler has a unique business model that integrates with drug discovery companies and aligns everyday business operations with priorities of the customer. This ensures a robust client pipeline, superior customer service, lower costs, and royalty returns on key products.
Learn More
February 21, 2024
Charles River Laboratories International, Inc. today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry, Manufacturing and Controls) platform. This new alliance provides early-stage biotechnology companies a unique solution to rapidly transition from pre-clinical activities to first-in-human clinical trials. Combining Charles River’s industry-leading experience in antibody discovery services, safety, and analytics with Wheeler’s Portable CMC® platform will accelerate therapeutic discovery to IND submission timelines.
Read More
October 17, 2023
Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and University of Missouri. With this round of funding, Nucleus RadioPharma will establish multiple new manufacturing facilities around the country, including Rochester, Minnesota, near Mayo Clinic, and build novel technology for the development, manufacturing, and distribution of radiopharmaceuticals.
Read More